DORAS
metadata only
Engineering of Nanomaterials for Cancer Therapy (ENACT)
The therapeutic efficacy of numerous anti-cancer drugs is often compromised by premature degradation or insufficient bioavailability during oral or intraven- ous administration. Addressing these limitations, targeted drug delivery to can- cer sites has emerged as a promising approach. This thesis ex
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A review on nanotechnology in drug delivery systems for cancer therapy#214723
- Cascade Therapy With Doxorubicin and Survivin-Targeted Tailored Nanoparticles: an Effective Alternative for Sensitization of Cancer Cells To Chemotherapy#681779
- Tumor cell membrane‑coated MOF‑199 nanoparticles co‑loaded with auranofin and celecoxib enhance single‑dose radiotherapy and anti‑PD‑L1 therapy in cervical cancer.#1167087
- Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#242229
- Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives.#240444
Record · ID 1154314
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive